Where can I read TECH's latest 10-K?

TECH's latest annual report, a 10-K, was filed on Aug 24, 2026 for the fiscal year ended Jun 30, 2026. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.

When did TECH last file an 8-K?

On Nov 4, 2026 it covered other events. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 12, 2026.

Are TECH insiders buying or selling?

Over the last 13 months insiders sold $437K in 2 sales and bought nothing on the open market; 101 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Herr Amy E. (Director) sold 6,636 shares on May 8, 2026 for $320K. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.

How many SEC filings has TECH made?

1,279 filings are on EDGAR under the registrant records that have been Bio-Techne, going back to 1995; 708 of them are insider ownership forms (Forms 3, 4, 5 and 144).

Data provided bySource: Twelve Data

TECH

$72.78+0.17%

as of close, Nov 6, 2026

☾ AH $72.78 +0.17%

Bio-TechneStock · HealthcareS&P 500 Equal Weight · 0.3% of RSPNasdaq Composite · 0.03% of ONEQS&P 500 · 0.02% of SPYRussell 1000 · 0.02% of IWBUS Stock Market · 0.02% of VTIRussell 3000 · 0.02% of IWV

PeersDXCMHALOBMRNCHRWFTVASND

Share this page

Head-to-head:Compare with DXCM or any ticker →

TECH SEC filings (2026)

CIK 842023 · Biological Products, (No Diagnostic Substances) (SIC 2836) · incorporated in MN · fiscal year ends in June

1,279 filings on EDGAR since 1995 · 35 annual, 97 quarterly, 187 current · financial statements · earnings

Latest 10-K

Aug 24, 2026

fiscal year to Jun 30, 2026

Latest 10-Q

Nov 6, 2026

quarter to Sep 30, 2026

Latest 8-K

Nov 4, 2026

Other events

Last earnings release

Aug 12, 2026

$0.49 vs $0.46 · ▲ 0.1%

Filings on file

1,279

since 1995, 708 insider forms

What happened, last 12 months#

Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.

Insider transactions#

What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.

Over the last 13 months insiders sold $437K in 2 sales and bought nothing on the open market; 101 other transactions (awards, exercises, tax withholding, gifts and plan purchases).

Date	Insider	Action	Shares	Price	Value	Held after	Filing
May 8, 2026Form 4	Herr Amy E.DirectorSold · $320K · 6,636 sh	Sold	6,636	$48.28	$320K	200	Form 4
Feb 17, 2026Form 4	Herr Amy E.DirectorSold · $117K · 1,976 sh	Sold	1,976	$59.11	$117K	200	Form 4

Awards, exercises, withholding and plan purchases · 101 transactions

Date	Insider	Action	Shares	Price	Value	Held after	Filing
Nov 1, 2026Form 4	Hippel JamesCFOTax withholding · $370K · 5,096 sh	Tax withholding	5,096	$72.66	$370K	176,720	Form 4
Nov 1, 2026Form 4	Kelderman KimChief Executive Officer · DirectorTax withholding · $173K · 2,385 sh	Tax withholding	2,385	$72.66	$173K	80,509	Form 4
Nov 1, 2026Form 4	Hippel JamesCFOExercise or conversion · $0 · 11,545 sh	Exercise or conversion	11,545	$0.00	$0	181,816	Form 4
Nov 1, 2026Form 4	Hippel JamesCFOExercise or conversion · Restricted Stock Units · $0 · 11,545 sh	Exercise or conversion· Restricted Stock Units	11,545	$0.00	$0	11,544	Form 4
Oct 29, 2026Form 4	BAUMGARTNER ROBERT VDirectorAward · $0 · 2,750 sh	Award	2,750	$0.00	$0	59,634	Form 4
Oct 29, 2026Form 4	Bushman Julie LDirectorAward · $0 · 2,750 sh	Award	2,750	$0.00	$0	11,525	Form 4
Oct 29, 2026Form 4	HIGGINS JOHN LDirectorAward · $0 · 2,750 sh	Award	2,750	$0.00	$0	80,004	Form 4
Oct 29, 2026Form 4	KEEGAN JOSEPH DDirectorAward · $0 · 2,750 sh	Award	2,750	$0.00	$0	18,161	Form 4
Oct 29, 2026Form 4	Herr Amy E.DirectorAward · $0 · 2,750 sh	Award	2,750	$0.00	$0	5,430	Form 4
Oct 29, 2026Form 4	Klimovsky Judith V.DirectorAward · $0 · 2,750 sh	Award	2,750	$0.00	$0	6,532	Form 4
Oct 29, 2026Form 4	Seth AlpnaDirectorAward · $0 · 2,750 sh	Award	2,750	$0.00	$0	18,161	Form 4
Oct 29, 2026Form 4	Vessey RupertDirectorAward · $0 · 2,750 sh	Award	2,750	$0.00	$0	13,737	Form 4
Sep 28, 2026Form 4	HIGGINS JOHN LDirectorTax withholding · $403K · 5,562 sh	Tax withholding	5,562	$72.51	$403K	77,254	Form 4
Sep 28, 2026Form 4	HIGGINS JOHN LDirectorExercise or conversion · $0 · 15,940 sh	Exercise or conversion	15,940	$0.00	$0	82,816	Form 4
Sep 28, 2026Form 4	HIGGINS JOHN LDirectorExercise or conversion · Stock Options (Right to Buy) · $0 · 15,940 sh	Exercise or conversion· Stock Options (Right to Buy)	15,940	$0.00	$0	0	Form 4
Sep 22, 2026Form 4	BAUMGARTNER ROBERT VDirectorTax withholding · $403K · 5,559 sh	Tax withholding	5,559	$72.55	$403K	56,884	Form 4
Sep 22, 2026Form 4	BAUMGARTNER ROBERT VDirectorExercise or conversion · $0 · 15,940 sh	Exercise or conversion	15,940	$0.00	$0	62,443	Form 4
Sep 22, 2026Form 4	BAUMGARTNER ROBERT VDirectorExercise or conversion · Stock Options (Right to Buy) · $0 · 15,940 sh	Exercise or conversion· Stock Options (Right to Buy)	15,940	$0.00	$0	0	Form 4
Aug 17, 2026Form 4	Kelderman KimChief Executive Officer · DirectorAward · Restricted Stock Units · $0 · 151,172 sh	Award· Restricted Stock Units	151,172	$0.00	$0	93,582	Form 4
Aug 17, 2026Form 4	Hippel JamesCFOAward · Restricted Stock Units · $0 · 58,897 sh	Award· Restricted Stock Units	58,897	$0.00	$0	36,459	Form 4
Aug 17, 2026Form 4	Geist WilliamPRESIDENT, PROTEIN SCIENCESAward · Restricted Stock Units · $0 · 38,747 sh	Award· Restricted Stock Units	38,747	$0.00	$0	23,985	Form 4
Aug 17, 2026Form 4	Bohnen ShaneSVP - General CounselAward · Restricted Stock Units · $0 · 29,776 sh	Award· Restricted Stock Units	29,776	$0.00	$0	18,432	Form 4
Aug 17, 2026Form 4	Crouse Steven C.President - Diag & Spatial BiAward · Restricted Stock Units · $0 · 22,842 sh	Award· Restricted Stock Units	22,842	$0.00	$0	14,140	Form 4
Aug 17, 2026Form 4	Herr Amy E.DirectorAward · Restricted Stock Units · $0 · 1,381 sh	Award· Restricted Stock Units	1,381	$0.00	$0	1,381	Form 4
Aug 15, 2026Form 4 ×2	Kelderman KimChief Executive Officer · DirectorTax withholding · $1.6M · 21,776 sh	Tax withholding	21,776	$72.40	$1.6M	82,894	Form 4 ×2
Aug 15, 2026Form 4 ×2	Hippel JamesCFOTax withholding · $632K · 8,733 sh	Tax withholding	8,733	$72.40	$632K	170,271	Form 4 ×2
Aug 15, 2026Form 4 ×2	Geist WilliamPRESIDENT, PROTEIN SCIENCESTax withholding · $289K · 3,995 sh	Tax withholding	3,995	$72.40	$289K	25,031	Form 4 ×2
Aug 15, 2026Form 4 ×2	Bohnen ShaneSVP - General CounselTax withholding · $196K · 2,709 sh	Tax withholding	2,709	$72.40	$196K	10,407	Form 4 ×2
Aug 15, 2026Form 4	Crouse Steven C.President - Diag & Spatial BiTax withholding · $141K · 1,947 sh	Tax withholding	1,947	$72.40	$141K	10,237	Form 4
Aug 15, 2026Form 4	Herr Amy E.DirectorTax withholding · $15K · 213 sh	Tax withholding	213	$72.40	$15K	576	Form 4
Aug 15, 2026Form 4 ×2	Kelderman KimChief Executive Officer · DirectorOther · Performance Stock Options … · $0 · 92,706 sh	Other· Performance Stock Options …	92,706	$0.00	$0	1,996	Form 4 ×2
Aug 15, 2026Form 4 ×2	Hippel JamesCFOOther · Performance Stock Options … · $0 · 69,425 sh	Other· Performance Stock Options …	69,425	$0.00	$0	2,871	Form 4 ×2
Aug 15, 2026Form 4 ×2	Geist WilliamPRESIDENT, PROTEIN SCIENCESOther · Performance Stock Options … · $0 · 45,443 sh	Other· Performance Stock Options …	45,443	$0.00	$0	1,879	Form 4 ×2
Aug 15, 2026Form 4 ×2	Kelderman KimChief Executive Officer · DirectorExercise or conversion · $0 · 43,206 sh	Exercise or conversion	43,206	$0.00	$0	93,849	Form 4 ×2
Aug 15, 2026Form 4 ×2	Kelderman KimChief Executive Officer · DirectorExercise or conversion · Restricted Stock Units · $0 · 40,656 sh	Exercise or conversion· Restricted Stock Units	40,656	$0.00	$0	23,569	Form 4 ×2
Aug 15, 2026Form 4 ×2	Kelderman KimChief Executive Officer · DirectorOther · Performance Restricted Sto… · $0 · 34,042 sh	Other· Performance Restricted Sto…	34,042	$0.00	$0	0	Form 4 ×2
Aug 15, 2026Form 4 ×2	Hippel JamesCFOOther · Performance Restricted Sto… · $0 · 25,797 sh	Other· Performance Restricted Sto…	25,797	$0.00	$0	0	Form 4 ×2
Aug 15, 2026Form 4 ×2	Bohnen ShaneSVP - General CounselOther · Performance Stock Option (… · $0 · 24,046 sh	Other· Performance Stock Option (…	24,046	$0.00	$0	995	Form 4 ×2
Aug 15, 2026Form 4 ×2	Hippel JamesCFOExercise or conversion · $0 · 19,759 sh	Exercise or conversion	19,759	$0.00	$0	174,694	Form 4 ×2
Aug 15, 2026Form 4 ×2	Hippel JamesCFOExercise or conversion · Restricted Stock Units · $0 · 17,826 sh	Exercise or conversion· Restricted Stock Units	17,826	$0.00	$0	9,807	Form 4 ×2
Aug 15, 2026Form 4 ×2	Geist WilliamPRESIDENT, PROTEIN SCIENCESExercise or conversion · $0 · 12,963 sh	Exercise or conversion	12,963	$0.00	$0	27,050	Form 4 ×2
Aug 15, 2026Form 4 ×2	Geist WilliamPRESIDENT, PROTEIN SCIENCESExercise or conversion · Restricted Stock Units · $0 · 11,698 sh	Exercise or conversion· Restricted Stock Units	11,698	$0.00	$0	6,452	Form 4 ×2
Aug 15, 2026Form 4 ×2	Geist WilliamPRESIDENT, PROTEIN SCIENCESOther · Performance Restricted Sto… · $0 · 9,205 sh	Other· Performance Restricted Sto…	9,205	$0.00	$0	8,376	Form 4 ×2
Aug 15, 2026Form 4 ×2	Geist WilliamPRESIDENT, PROTEIN SCIENCESExercise or conversion · Performance Restricted Sto… · $0 · 8,943 sh	Exercise or conversion· Performance Restricted Sto…	8,943	$0.00	$0	0	Form 4 ×2
Aug 15, 2026Form 4 ×2	Bohnen ShaneSVP - General CounselOther · Performance Restricted Sto… · $0 · 8,934 sh	Other· Performance Restricted Sto…	8,934	$0.00	$0	0	Form 4 ×2
Aug 15, 2026Form 4 ×2	Bohnen ShaneSVP - General CounselExercise or conversion · $0 · 8,770 sh	Exercise or conversion	8,770	$0.00	$0	11,773	Form 4 ×2
Aug 15, 2026Form 4 ×2	Bohnen ShaneSVP - General CounselExercise or conversion · Restricted Stock Units · $0 · 8,100 sh	Exercise or conversion· Restricted Stock Units	8,100	$0.00	$0	4,664	Form 4 ×2
Aug 15, 2026Form 4	Crouse Steven C.President - Diag & Spatial BiExercise or conversion · $0 · 5,423 sh	Exercise or conversion	5,423	$0.00	$0	12,184	Form 4
Aug 15, 2026Form 4	Crouse Steven C.President - Diag & Spatial BiExercise or conversion · Restricted Stock Units · $0 · 5,423 sh	Exercise or conversion· Restricted Stock Units	5,423	$0.00	$0	4,353	Form 4
Aug 15, 2026Form 4 ×2	Kelderman KimChief Executive Officer · DirectorExercise or conversion · Performance Restricted Sto… · $0 · 2,550 sh	Exercise or conversion· Performance Restricted Sto…	2,550	$0.00	$0	8,698	Form 4 ×2
Aug 15, 2026Form 4 ×2	Hippel JamesCFOExercise or conversion · Performance Restricted Sto… · $0 · 1,933 sh	Exercise or conversion· Performance Restricted Sto…	1,933	$0.00	$0	12,798	Form 4 ×2
Aug 15, 2026Form 4 ×2	Bohnen ShaneSVP - General CounselExercise or conversion · Performance Restricted Sto… · $0 · 670 sh	Exercise or conversion· Performance Restricted Sto…	670	$0.00	$0	4,432	Form 4 ×2
Aug 15, 2026Form 4	Herr Amy E.DirectorExercise or conversion · $0 · 589 sh	Exercise or conversion	589	$0.00	$0	789	Form 4
Aug 15, 2026Form 4	Herr Amy E.DirectorExercise or conversion · Restricted Stock Units · $0 · 589 sh	Exercise or conversion· Restricted Stock Units	589	$0.00	$0	621	Form 4
Jul 29, 2026Form 4	Hippel JamesCFOTax withholding · $3.7M · 51,024 sh	Tax withholding	51,024	$72.03	$3.7M	164,714	Form 4
Jul 29, 2026Form 4	Hippel JamesCFOExercise or conversion · $3.0M · 62,068 sh	Exercise or conversion	62,068	$47.60	$3.0M	215,738	Form 4
Jul 29, 2026Form 4	Hippel JamesCFOExercise or conversion · Stock Options (Right to Buy) · $0 · 62,068 sh	Exercise or conversion· Stock Options (Right to Buy)	62,068	$0.00	$0	0	Form 4
Jul 28, 2026Form 4	Kelderman KimChief Executive Officer · DirectorTax withholding · $2.1M · 28,686 sh	Tax withholding	28,686	$72.07	$2.1M	72,113	Form 4
Jul 28, 2026Form 4	Kelderman KimChief Executive Officer · DirectorExercise or conversion · $1.7M · 35,000 sh	Exercise or conversion	35,000	$47.60	$1.7M	100,799	Form 4
Jul 28, 2026Form 4	Kelderman KimChief Executive Officer · DirectorExercise or conversion · Stock Option (Right to Buy) · $0 · 35,000 sh	Exercise or conversion· Stock Option (Right to Buy)	35,000	$0.00	$0	0	Form 4
Jul 23, 2026Form 4	Bohnen ShaneSVP - General CounselTax withholding · $25K · 344 sh	Tax withholding	344	$71.77	$25K	7,353	Form 4
Jul 23, 2026Form 4	Bohnen ShaneSVP - General CounselExercise or conversion · $21K · 448 sh	Exercise or conversion	448	$47.60	$21K	7,697	Form 4
Jul 23, 2026Form 4	Bohnen ShaneSVP - General CounselExercise or conversion · Stock Option (Right to Buy) · $0 · 448 sh	Exercise or conversion· Stock Option (Right to Buy)	448	$0.00	$0	0	Form 4
Jun 2, 2026Form 4	Crouse Steven C.President - Diag & Spatial BiTax withholding · $11K · 216 sh	Tax withholding	216	$49.77	$11K	6,761	Form 4
Jun 2, 2026Form 4	Crouse Steven C.President - Diag & Spatial BiExercise or conversion · — · 600 sh	Exercise or conversion	600	—	—	6,977	Form 4
Jun 2, 2026Form 4	Crouse Steven C.President - Diag & Spatial BiExercise or conversion · Restricted Stock Units · $0 · 600 sh	Exercise or conversion· Restricted Stock Units	600	$0.00	$0	1,200	Form 4
May 8, 2026Form 4	Herr Amy E.DirectorExercise or conversion · $316K · 6,636 sh	Exercise or conversion	6,636	$47.60	$316K	6,836	Form 4
May 8, 2026Form 4	Herr Amy E.DirectorExercise or conversion · Stock Option (Right to Buy) · $0 · 6,636 sh	Exercise or conversion· Stock Option (Right to Buy)	6,636	$0.00	$0	0	Form 4
May 5, 2026Form 4	Hippel JamesCFOTax withholding · $3.2M · 56,955 sh	Tax withholding	56,955	$56.68	$3.2M	153,670	Form 4
May 5, 2026Form 4	Hippel JamesCFOExercise or conversion · $3.0M · 62,000 sh	Exercise or conversion	62,000	$47.60	$3.0M	210,625	Form 4
May 5, 2026Form 4	Kelderman KimChief Executive Officer · DirectorTax withholding · $1.4M · 23,951 sh	Tax withholding	23,951	$56.68	$1.4M	65,799	Form 4
May 5, 2026Form 4	Kelderman KimChief Executive Officer · DirectorExercise or conversion · $1.3M · 26,692 sh	Exercise or conversion	26,692	$47.60	$1.3M	89,750	Form 4
May 5, 2026Form 4	Bohnen ShaneSVP - General CounselTax withholding · $400K · 7,055 sh	Tax withholding	7,055	$56.68	$400K	7,249	Form 4
May 5, 2026Form 4	Bohnen ShaneSVP - General CounselExercise or conversion · $400K · 8,400 sh	Exercise or conversion	8,400	$47.60	$400K	14,304	Form 4
May 5, 2026Form 4	Hippel JamesCFOExercise or conversion · Stock Options (Right to Buy) · $0 · 62,000 sh	Exercise or conversion· Stock Options (Right to Buy)	62,000	$0.00	$0	62,068	Form 4
May 5, 2026Form 4	Kelderman KimChief Executive Officer · DirectorExercise or conversion · Stock Option (Right to Buy) · $0 · 26,692 sh	Exercise or conversion· Stock Option (Right to Buy)	26,692	$0.00	$0	35,000	Form 4
May 5, 2026Form 4	Bohnen ShaneSVP - General CounselExercise or conversion · Stock Option (Right to Buy) · $0 · 8,400 sh	Exercise or conversion· Stock Option (Right to Buy)	8,400	$0.00	$0	448	Form 4
May 1, 2026Form 4	Crouse Steven C.President - Diag & Spatial BiTax withholding · $17K · 311 sh	Tax withholding	311	$55.02	$17K	6,337	Form 4
May 1, 2026Form 4	Crouse Steven C.President - Diag & Spatial BiExercise or conversion · — · 794 sh	Exercise or conversion	794	—	—	6,688	Form 4
May 1, 2026Form 4	Crouse Steven C.President - Diag & Spatial BiExercise or conversion · Restricted Stock Units · $0 · 794 sh	Exercise or conversion· Restricted Stock Units	794	$0.00	$0	794	Form 4
Apr 22, 2026Form 4	Hippel JamesCFOTax withholding · $3.3M · 56,097 sh	Tax withholding	56,097	$58.58	$3.3M	148,625	Form 4
Apr 22, 2026Form 4	Kelderman KimChief Executive Officer · DirectorTax withholding · $80K · 1,363 sh	Tax withholding	1,363	$58.58	$80K	63,058	Form 4
Apr 22, 2026Form 4	Hippel JamesCFOExercise or conversion · $0 · 62,000 sh	Exercise or conversion	62,000	$0.00	$0	204,722	Form 4
Apr 22, 2026Form 4	Hippel JamesCFOExercise or conversion · Stock Options (Right to Buy) · $0 · 62,000 sh	Exercise or conversion· Stock Options (Right to Buy)	62,000	$0.00	$0	124,068	Form 4
Apr 22, 2026Form 4	Kelderman KimChief Executive Officer · DirectorExercise or conversion · $0 · 11,344 sh	Exercise or conversion	11,344	$0.00	$0	64,421	Form 4
Apr 22, 2026Form 4	Kelderman KimChief Executive Officer · DirectorExercise or conversion · Stock Option (Right to Buy) · $0 · 11,344 sh	Exercise or conversion· Stock Option (Right to Buy)	11,344	$0.00	$0	61,692	Form 4
Apr 14, 2026Form 4	Kelderman KimChief Executive Officer · DirectorTax withholding · $1.9M · 32,088 sh	Tax withholding	32,088	$58.66	$1.9M	53,077	Form 4
Apr 14, 2026Form 4	Kelderman KimChief Executive Officer · DirectorExercise or conversion · $0 · 36,500 sh	Exercise or conversion	36,500	$0.00	$0	85,165	Form 4
Apr 14, 2026Form 4	Kelderman KimChief Executive Officer · DirectorExercise or conversion · Stock Option (Right to Buy) · $0 · 36,500 sh	Exercise or conversion· Stock Option (Right to Buy)	36,500	$0.00	$0	73,036	Form 4
Apr 3, 2026Form 4	Bohnen ShaneSVP - General CounselTax withholding · $39K · 740 sh	Tax withholding	740	$53.13	$39K	5,904	Form 4
Apr 3, 2026Form 4	Bohnen ShaneSVP - General CounselExercise or conversion · $0 · 2,259 sh	Exercise or conversion	2,259	$0.00	$0	6,644	Form 4
Apr 3, 2026Form 4	Bohnen ShaneSVP - General CounselExercise or conversion · Restricted Stock Units · $0 · 2,259 sh	Exercise or conversion· Restricted Stock Units	2,259	$0.00	$0	0	Form 4
Mar 2, 2026Form 4	Crouse Steven C.President - Diag & Spatial BiAward · Performance Restricted Sto… · $0 · 2,387 sh	Award· Performance Restricted Sto…	2,387	$0.00	$0	2,387	Form 4
Mar 2, 2026Form 4	Crouse Steven C.President - Diag & Spatial BiAward · Stock Option (right to buy) · $0 · 1,911 sh	Award· Stock Option (right to buy)	1,911	$0.00	$0	1,911	Form 4
Mar 2, 2026Form 4	Crouse Steven C.President - Diag & Spatial BiAward · Restricted Stock Units · $0 · 735 sh	Award· Restricted Stock Units	735	$0.00	$0	735	Form 4
Feb 3, 2026Form 4	Herr Amy E.DirectorTax withholding · $1,034 · 16 sh	Tax withholding	16	$64.63	$1,034	2,176	Form 4
Feb 3, 2026Form 4	Herr Amy E.DirectorExercise or conversion · $0 · 38 sh	Exercise or conversion	38	$0.00	$0	2,192	Form 4
Feb 3, 2026Form 4	Herr Amy E.DirectorExercise or conversion · Restricted Stock Units · $0 · 38 sh	Exercise or conversion· Restricted Stock Units	38	$0.00	$0	77	Form 4
Feb 1, 2026Form 4	McManus MatthewPresident - Diag & Spatial BioTax withholding · $107K · 1,665 sh	Tax withholding	1,665	$64.09	$107K	7,691	Form 4
Feb 1, 2026Form 4	McManus MatthewPresident - Diag & Spatial BioExercise or conversion · $0 · 4,621 sh	Exercise or conversion	4,621	$0.00	$0	9,356	Form 4
Feb 1, 2026Form 4	McManus MatthewPresident - Diag & Spatial BioExercise or conversion · Restricted Stock Units · $0 · 4,621 sh	Exercise or conversion· Restricted Stock Units	4,621	$0.00	$0	4,620	Form 4

Reports and proxy statements#

Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.

2026 · 22 filings

Filed	Form	What it is	Period
Nov 6, 202610-Q	10-Q	Quarterly report, Q1 FY2027 — revenue $299.7M (+5% y/y), net income $28.3M, EPS $0.18	Sep 30, 2026
Nov 4, 20268-K	8-K	Other events	Nov 3, 2026
Oct 28, 202610-K/A	10-K/A	Annual report, amended	Jun 30, 2026
Sep 23, 20268-K	8-K	Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, GermanyShareholder vote results; Regulation FD disclosure	Sep 23, 2026
Sep 14, 2026DEFA14A	DEFA14A	Additional proxy materials	—
Sep 14, 20268-K	8-K	Other events	Sep 14, 2026
Sep 9, 2026DEFA14A	DEFA14A	Additional proxy materials	—
Sep 2, 2026DEFA14A	DEFA14A	Additional proxy materials	—
Aug 25, 2026DEFA14A	DEFA14A	Additional proxy materials	—
Aug 24, 202610-K	10-K	Annual report, FY2026 — revenue $1.22B (−0% y/y), net income $181.9M, EPS $1.16	Jun 30, 2026
Aug 20, 2026DEFM14A	DEFM14A	Merger proxy statement	—
Aug 12, 20268-K	8-K	Earnings release — EPS $0.49 vs $0.46 est. (+6.5%); revenue $321.2M (+1% y/y) 0.1%	Aug 12, 2026
Aug 10, 2026PREM14A	PREM14A	Proxy statements	Aug 10, 2026
Jul 9, 2026DEFA14A	DEFA14A	Additional proxy materials	—
Jun 26, 20268-K	8-K	Material definitive agreement; Directors or officers; compensation	Jun 23, 2026
Jun 25, 2026DEFA14A	DEFA14A	Additional proxy materials	—
Jun 25, 20268-K	8-K	Regulation FD disclosure	Jun 25, 2026
May 6, 202610-Q	10-Q	Quarterly report, Q3 2026 — revenue $311.4M (−2% y/y), net income $51.0M, EPS $0.32	Mar 31, 2026
May 6, 20268-K	8-K	Earnings release — EPS $0.48 vs $0.48 est. (+0.0%); revenue $311.4M (−2% y/y) 16.4%	May 6, 2026
Feb 11, 20268-K	8-K	Bio-Techne Announces Changes to its Leadership TeamDirectors or officers; compensation; Other events	Feb 9, 2026
Feb 4, 202610-Q	10-Q	Quarterly report, Q2 FY2026 — revenue $295.9M (−0% y/y), net income $38.0M, EPS $0.24	Dec 31, 2025
Feb 4, 20268-K	8-K	Earnings release — EPS $0.39 vs $0.34 est. (+14.7%); revenue $295.9M (−0% y/y) 6.3%	Feb 4, 2026

2025 · 13 filings

Filed	Form	What it is	Period
Nov 5, 202510-Q	10-Q	Quarterly report, Q1 FY2026 — revenue $286.6M (−1% y/y), net income $38.2M, EPS $0.24	Sep 30, 2025
Nov 5, 20258-K	8-K	Earnings release — EPS $0.36 vs $0.36 est. (+0.0%); revenue $286.6M (−1% y/y) 1.9%	Oct 30, 2025
Sep 19, 2025ARS	ARS	Annual report to shareholders	Jun 30, 2025
Sep 19, 2025DEFA14A	DEFA14A	Additional proxy materials	—
Sep 19, 2025DEF 14A	DEF 14A	Proxy statement	Oct 30, 2025
Aug 22, 202510-K	10-K	Annual report, FY2025 — revenue $1.22B (+5% y/y), net income $73.4M, EPS $0.46	Jun 30, 2025
Aug 6, 20258-K	8-K	Earnings release — EPS $0.51 vs $0.46 est. (+10.9%); revenue $317.0M (+4% y/y) 8.7%	Aug 6, 2025
May 8, 202510-Q	10-Q	Quarterly report, Q3 2025 — revenue $316.2M (+4% y/y), net income $22.6M, EPS $0.14	Mar 31, 2025
May 7, 20258-K	8-K	Earnings release — EPS $0.50 vs $0.45 est. (+11.1%); revenue $316.2M (+4% y/y) 2.2%	May 7, 2025
May 6, 20258-K	8-K	Regulation FD disclosure	Apr 30, 2025
Mar 4, 20258-K	8-K	Directors or officers; compensation	Feb 26, 2025
Feb 6, 202510-Q	10-Q	Quarterly report, Q2 FY2025 — revenue $297.0M (+9% y/y), net income $34.9M, EPS $0.22	Dec 31, 2024
Feb 5, 20258-K	8-K	Earnings release — EPS $0.35 vs $0.33 est. (+6.1%); revenue $297.0M (+9% y/y) 3.7%	Jan 30, 2025

2024 · 14 filings

Filed	Form	What it is	Period
Nov 5, 20248-K	8-K	Directors or officers; compensation	Oct 30, 2024
Nov 5, 202410-Q	10-Q	Quarterly report, Q1 FY2025 — revenue $289.5M (+5% y/y), net income $33.6M, EPS $0.21	Sep 30, 2024
Oct 30, 20248-K	8-K	Earnings release — EPS $0.37 vs $0.34 est. (+8.8%); revenue $289.5M (+5% y/y) 7.5%	Oct 25, 2024
Sep 12, 2024ARS	ARS	Annual report to shareholders	Jun 30, 2024
Sep 12, 2024DEFA14A	DEFA14A	Additional proxy materials	—
Sep 12, 2024DEF 14A	DEF 14A	Proxy statement	Oct 24, 2024
Aug 22, 202410-K	10-K	Annual report, FY2024 — revenue $1.16B (+2% y/y), net income $168.1M, EPS $1.05	Jun 30, 2024
Aug 7, 20248-K	8-K	Earnings release — EPS $0.49 vs $0.44 est. (+11.4%); revenue $306.1M (+2% y/y) 9.5%	Aug 7, 2024
May 6, 202410-Q	10-Q	Quarterly report, Q3 2024 — revenue $303.4M (+3% y/y), net income $49.1M, EPS $0.31	Mar 31, 2024
May 1, 20248-K	8-K	Earnings release — EPS $0.44 vs $0.40 est. (+10.0%); revenue $303.4M (+3% y/y) 16.2%	May 1, 2024
Apr 30, 20248-K	8-K	Directors or officers; compensation; Other events	Apr 24, 2024
Feb 7, 202410-Q	10-Q	Quarterly report, Q2 FY2024 — revenue $272.6M (+0% y/y), net income $27.5M, EPS $0.17	Dec 31, 2023
Feb 1, 20248-K	8-K	Earnings release — EPS $0.33 vs $0.36 est. (−8.3%); revenue $272.6M (+0% y/y) 2.5%	Feb 1, 2024
Jan 8, 20248-K	8-K	Directors or officers; compensation; Other events	Jan 5, 2024

2023 · 15 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Filed	Form	What it is	Period
Nov 7, 202310-Q	10-Q	Quarterly report, Q1 FY2024 — revenue $276.9M (+3% y/y), net income $51.0M, EPS $0.31	Sep 30, 2023
Sep 13, 2023ARS	ARS	Annual report to shareholders	Jun 30, 2023
Sep 13, 2023DEFA14A	DEFA14A	Additional proxy materials	—
Sep 13, 2023DEF 14A	DEF 14A	Proxy statement	Oct 26, 2023
Aug 23, 202310-K	10-K	Annual report, FY2023 — revenue $1.14B (+3% y/y), net income $285.3M, EPS $1.76	Jun 30, 2023
May 8, 202310-Q	10-Q	Quarterly report, Q3 2023 — revenue $294.1M (+1% y/y), net income $70.2M, EPS $0.43	Mar 31, 2023
Feb 7, 202310-Q	10-Q	Quarterly report, Q2 FY2023 — revenue $271.6M (+1% y/y), net income $50.0M, EPS $0.31	Dec 31, 2022

8 current reports (8-K) not listed; the year is on EDGAR.

2022 · 14 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Filed	Form	What it is	Period
Nov 7, 202210-Q	10-Q	Quarterly report, Q1 FY2023 — revenue $269.7M (+5% y/y), net income $89.6M, EPS $0.55	Sep 30, 2022
Sep 14, 2022DEFA14A	DEFA14A	Additional proxy materials	—
Sep 14, 2022DEF 14A	DEF 14A	Proxy statement	Oct 27, 2022
Sep 1, 2022PRE 14A	PRE 14A	Preliminary proxy statement	Oct 27, 2022
Aug 24, 202210-K	10-K	Annual report, FY2022 — revenue $1.11B (+19% y/y), net income $272.1M, EPS $1.66	Jun 30, 2022
May 9, 202210-Q	10-Q	Quarterly report, Q3 2022 — revenue $290.4M (+19% y/y), net income $60.7M, EPS $0.37	Mar 31, 2022
Feb 7, 202210-Q	10-Q	Quarterly report, Q2 FY2022 — revenue $269.3M (+20% y/y), net income $80.2M, EPS $0.49	Dec 31, 2021

7 current reports (8-K) not listed; the year is on EDGAR.

2021 · 12 filings — 6 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Filed	Form	What it is	Period
Nov 8, 202110-Q	10-Q	Quarterly report, Q1 FY2022 — revenue $257.7M (+26% y/y), net income $69.6M, EPS $1.69	Sep 30, 2021
Sep 15, 2021DEFA14A	DEFA14A	Additional proxy materials	—
Sep 14, 2021DEF 14A	DEF 14A	Proxy statement	Oct 28, 2021
Aug 25, 202110-K	10-K	Annual report, FY2021 — revenue $931.0M (+26% y/y), net income $140.4M, EPS $0.87	Jun 30, 2021
May 7, 202110-Q	10-Q	Quarterly report, Q3 2021 — revenue $243.6M (+25% y/y), net income $45.8M, EPS $1.12	Mar 31, 2021
Feb 8, 202110-Q	10-Q	Quarterly report, Q2 FY2021 — revenue $224.3M (+21% y/y), net income $46.3M, EPS $1.15	Dec 31, 2020

6 current reports (8-K) not listed; the year is on EDGAR.

2020 · 12 filings — 6 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Filed	Form	What it is	Period
Nov 9, 202010-Q	10-Q	Quarterly report, Q1 FY2021 — revenue $204.2M (+11% y/y), net income $33.4M, EPS $0.83	Sep 30, 2020
Sep 15, 2020DEFA14A	DEFA14A	Additional proxy materials	—
Sep 15, 2020DEF 14A	DEF 14A	Proxy statement	Oct 29, 2020
Aug 26, 202010-K	10-K	Annual report, FY2020 — revenue $738.7M (+3% y/y), net income $229.3M, EPS $5.82	Jun 30, 2020
May 11, 202010-Q	10-Q	Quarterly report, Q3 2020 — revenue $194.7M (+5% y/y), net income $36.4M, EPS $0.92	Mar 31, 2020
Feb 6, 202010-Q	10-Q	Quarterly report, Q2 FY2020 — revenue $184.9M (+6% y/y), net income $119.6M, EPS $3.02	Dec 31, 2019

6 current reports (8-K) not listed; the year is on EDGAR.

2019 · 13 filings — 5 × 8-K, 3 × 10-Q, 2 × 10-K/A and 3 other forms

Filed	Form	What it is	Period
Nov 6, 201910-Q	10-Q	Quarterly report, Q1 FY2020 — revenue $183.2M (+12% y/y), net income $14.4M, EPS $0.37	Sep 30, 2019
Nov 6, 201910-K/A	10-K/A	Annual report, amended	Jun 30, 2019
Oct 9, 201910-K/A	10-K/A	Annual report, amended	Jun 30, 2019
Sep 9, 2019DEFA14A	DEFA14A	Additional proxy materials	—
Sep 9, 2019DEF 14A	DEF 14A	Proxy statement	Oct 24, 2019
Aug 28, 201910-K	10-K	Annual report	Jun 30, 2019
May 7, 201910-Q	10-Q	Quarterly report, Q3 2019 — revenue $184.9M (+13% y/y), net income $44.7M, EPS $1.15	Mar 31, 2019
Feb 7, 201910-Q	10-Q	Quarterly report, Q2 FY2019 — revenue $174.5M (+13% y/y), net income $17.6M, EPS $0.45	Dec 31, 2018

5 current reports (8-K) not listed; the year is on EDGAR.

2018 · 15 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Filed	Form	What it is	Period
Nov 7, 201810-Q	10-Q	Quarterly report, Q1 FY2019 — revenue $163.0M (+13% y/y), net income $17.4M, EPS $0.45	Sep 30, 2018
Sep 11, 2018DEFA14A	DEFA14A	Additional proxy materials	—
Sep 11, 2018DEF 14A	DEF 14A	Proxy statement	Oct 25, 2018
Aug 27, 201810-K	10-K	Annual report, FY2018 — revenue $643.0M (+14% y/y), net income $126.2M, EPS $3.31	Jun 30, 2018
May 9, 201810-Q	10-Q	Quarterly report, Q3 2018 — revenue $164.0M (+14% y/y), net income $19.7M, EPS $0.52	Mar 31, 2018
Feb 8, 201810-Q	10-Q	Quarterly report, Q2 FY2018 — revenue $154.2M (+17% y/y), net income $48.8M, EPS $1.29	Dec 31, 2017

9 current reports (8-K) not listed; the year is on EDGAR.

2017 · 13 filings — 5 × 8-K, 3 × 10-Q, 2 × 10-Q/A and 3 other forms

Filed	Form	What it is	Period
Nov 9, 201710-Q	10-Q	Quarterly report, Q1 FY2018 — revenue $144.6M (+11% y/y), net income $15.9M, EPS $0.42	Sep 30, 2017
Sep 12, 2017DEFA14A	DEFA14A	Additional proxy materials	—
Sep 12, 2017DEF 14A	DEF 14A	Proxy statement	Oct 26, 2017
Sep 7, 201710-K	10-K	Annual report, FY2017 — revenue $563.0M (+13% y/y), net income $76.1M, EPS $2.03	Jun 30, 2017
May 10, 201710-Q	10-Q	Quarterly report, Q3 2017 — revenue $144.0M (+10% y/y), net income $22.2M, EPS $0.59	Mar 31, 2017
Mar 21, 201710-Q/A	10-Q/A	Quarterly report, amended	Dec 31, 2016
Mar 21, 201710-Q/A	10-Q/A	Quarterly report, amended	Sep 30, 2016
Feb 9, 201710-Q	10-Q	Quarterly report, Q2 FY2017 — revenue $131.8M (+9% y/y), net income $7.5M, EPS $0.20	Dec 31, 2016

5 current reports (8-K) not listed; the year is on EDGAR.

2016 · 14 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Counted, not listed; the year is on EDGAR.

2015 · 15 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Counted, not listed; the year is on EDGAR.

2014 · 22 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 5 other forms

Counted, not listed; the year is on EDGAR.

2013 · 18 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Counted, not listed; the year is on EDGAR.

2012 · 16 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Counted, not listed; the year is on EDGAR.

2011 · 17 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Counted, not listed; the year is on EDGAR.

2010 · 15 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2009 · 15 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2008 · 10 filings — 5 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2007 · 12 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2006 · 9 filings — 4 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2005 · 12 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2004 · 11 filings — 6 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2003 · 8 filings — 3 × 10-Q, 3 × 8-K, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2002 · 6 filings — 3 × 10-Q, 1 × 10-K, 1 × 8-K and 1 other form

Counted, not listed; the year is on EDGAR.

2001 · 5 filings — 3 × 10-Q, 1 × 10-K, 1 × DEF 14A

Counted, not listed; the year is on EDGAR.

2000 · 6 filings — 3 × 10-Q, 1 × 10-K, 1 × DEF 14A and 1 other form

Counted, not listed; the year is on EDGAR.

1999 · 5 filings — 3 × 10-Q, 1 × 10-K, 1 × DEF 14A

Counted, not listed; the year is on EDGAR.

1998 · 7 filings — 3 × 10-Q, 1 × 10-K, 1 × 8-K and 2 other forms

Counted, not listed; the year is on EDGAR.

1997 · 5 filings — 3 × 10-Q, 1 × 10-K, 1 × DEF 14A

Counted, not listed; the year is on EDGAR.

1996 · 5 filings — 3 × 10-Q, 1 × 10-K, 1 × DEF 14A

Counted, not listed; the year is on EDGAR.

1995 · 5 filings — 2 × 10-Q, 1 × 10-K, 1 × DEF 14A and 1 other form

Counted, not listed; the year is on EDGAR.

Insider, ownership and other filings#

Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.

2026 · 54 filings — 41 × 4, 4 × 4/A, 3 × SCHEDULE 13G/A and 4 other forms

Filed	Form	What it is	Period
Nov 5, 2026SCHEDULE 13G/A	SCHEDULE 13G/A	Other filings	—
Nov 3, 20264	4	Insider transaction (Form 4)	Nov 1, 2026
Nov 3, 20264	4	Insider transaction (Form 4)	Nov 1, 2026
Nov 2, 20264/A	4/A	Insider transaction (Form 4), amended	Aug 15, 2026
Nov 2, 20264/A	4/A	Insider transaction (Form 4), amended	Aug 15, 2026
Nov 2, 20264/A	4/A	Insider transaction (Form 4), amended	Aug 15, 2026
Nov 2, 20264/A	4/A	Insider transaction (Form 4), amended	Aug 15, 2026
Nov 2, 20264	4	Insider transaction (Form 4)	Oct 29, 2026
Nov 2, 20264	4	Insider transaction (Form 4)	Oct 29, 2026
Nov 2, 20264	4	Insider transaction (Form 4)	Oct 29, 2026
Nov 2, 20264	4	Insider transaction (Form 4)	Oct 29, 2026
Nov 2, 20264	4	Insider transaction (Form 4)	Oct 29, 2026
Nov 2, 20264	4	Insider transaction (Form 4)	Oct 29, 2026
Nov 2, 20264	4	Insider transaction (Form 4)	Oct 29, 2026
Nov 2, 20264	4	Insider transaction (Form 4)	Oct 29, 2026
Sep 30, 20264	4	Insider transaction (Form 4)	Sep 28, 2026
Sep 24, 20264	4	Insider transaction (Form 4)	Sep 22, 2026
Aug 19, 20264	4	Insider transaction (Form 4)	Aug 17, 2026
Aug 19, 20264	4	Insider transaction (Form 4)	Aug 17, 2026
Aug 19, 20264	4	Insider transaction (Form 4)	Aug 17, 2026
Aug 19, 20264	4	Insider transaction (Form 4)	Aug 17, 2026
Aug 19, 20264	4	Insider transaction (Form 4)	Aug 17, 2026
Aug 19, 20264	4	Insider transaction (Form 4)	Aug 17, 2026
Aug 18, 20264	4	Insider transaction (Form 4)	Aug 15, 2026
Aug 18, 20264	4	Insider transaction (Form 4)	Aug 15, 2026

The newest 25 of 54 shown; the full year is on EDGAR.

2025 · 44 filings — 31 × 4, 5 × 144, 4 × SCHEDULE 13G/A and 3 other forms

Filed	Form	What it is	Period
Nov 14, 2025SCHEDULE 13G/A	SCHEDULE 13G/A	Other filings	—
Nov 5, 20254	4	Insider transaction (Form 4)	Nov 3, 2025
Nov 5, 20254	4	Insider transaction (Form 4)	Nov 3, 2025
Nov 5, 20254	4	Insider transaction (Form 4)	Nov 3, 2025
Nov 3, 20254	4	Insider transaction (Form 4)	Oct 30, 2025
Nov 3, 20254	4	Insider transaction (Form 4)	Oct 30, 2025
Nov 3, 20254	4	Insider transaction (Form 4)	Oct 30, 2025
Nov 3, 20254	4	Insider transaction (Form 4)	Oct 30, 2025
Nov 3, 20254	4	Insider transaction (Form 4)	Oct 30, 2025
Nov 3, 20254	4	Insider transaction (Form 4)	Oct 30, 2025
Nov 3, 20254	4	Insider transaction (Form 4)	Oct 30, 2025
Nov 3, 20254	4	Insider transaction (Form 4)	Oct 30, 2025
Aug 27, 20254	4	Insider transaction (Form 4)	Aug 25, 2025
Aug 27, 20254	4	Insider transaction (Form 4)	Aug 25, 2025
Aug 25, 2025144	144	Notice of proposed sale (Form 144)	—
Aug 25, 2025144	144	Notice of proposed sale (Form 144)	—
Aug 19, 20254	4	Insider transaction (Form 4)	Aug 15, 2025
Aug 19, 20254	4	Insider transaction (Form 4)	Aug 15, 2025
Aug 19, 20254	4	Insider transaction (Form 4)	Aug 15, 2025
Aug 19, 20254	4	Insider transaction (Form 4)	Aug 15, 2025
Aug 19, 20254	4	Insider transaction (Form 4)	Aug 15, 2025
Aug 19, 20254	4	Insider transaction (Form 4)	Aug 15, 2025
Aug 14, 2025SCHEDULE 13G/A	SCHEDULE 13G/A	Other filings	—
Aug 11, 20254	4	Insider transaction (Form 4)	Aug 7, 2025
Jul 31, 20254	4	Insider transaction (Form 4)	Jul 29, 2025

The newest 25 of 44 shown; the full year is on EDGAR.

2024 · 41 filings — 30 × 4, 4 × SC 13G/A, 3 × 144 and 3 other forms

Filed	Form	What it is	Period
Nov 14, 2024SC 13G	SC 13G	Passive holder above 5% (Schedule 13G)	—
Nov 8, 2024SC 13G/A	SC 13G/A	Passive holder above 5% (Schedule 13G), amended	—
Nov 5, 20244	4	Insider transaction (Form 4)	Nov 1, 2024
Nov 5, 20244	4	Insider transaction (Form 4)	Nov 1, 2024
Nov 5, 20244	4	Insider transaction (Form 4)	Nov 1, 2024
Oct 28, 20244	4	Insider transaction (Form 4)	Oct 24, 2024
Oct 28, 20244	4	Insider transaction (Form 4)	Oct 24, 2024
Oct 28, 20244	4	Insider transaction (Form 4)	Oct 24, 2024
Oct 28, 20244	4	Insider transaction (Form 4)	Oct 24, 2024
Oct 28, 20244	4	Insider transaction (Form 4)	Oct 24, 2024
Oct 28, 20244	4	Insider transaction (Form 4)	Oct 24, 2024
Oct 28, 20244	4	Insider transaction (Form 4)	Oct 24, 2024
Oct 28, 20244	4	Insider transaction (Form 4)	Oct 24, 2024
Oct 21, 2024SC 13G/A	SC 13G/A	Passive holder above 5% (Schedule 13G), amended	—
Sep 16, 20244	4	Insider transaction (Form 4)	Sep 12, 2024
Sep 3, 20244	4	Insider transaction (Form 4)	Aug 29, 2024
Aug 19, 20244	4	Insider transaction (Form 4)	Aug 15, 2024
Aug 19, 20244	4	Insider transaction (Form 4)	Aug 15, 2024
Aug 19, 20244	4	Insider transaction (Form 4)	Aug 15, 2024
Aug 19, 20244	4	Insider transaction (Form 4)	Aug 15, 2024
Aug 19, 20244	4	Insider transaction (Form 4)	Aug 15, 2024
Aug 12, 20244	4	Insider transaction (Form 4)	Aug 8, 2024
Aug 8, 2024144	144	Notice of proposed sale (Form 144)	—
Aug 6, 20244	4	Insider transaction (Form 4)	Aug 2, 2024
Aug 2, 20244	4	Insider transaction (Form 4)	Jul 31, 2024

The newest 25 of 41 shown; the full year is on EDGAR.

2023 · 47 filings — 30 × 4, 6 × 4/A, 3 × 144 and 6 other forms

Counted, not listed; the year is on EDGAR.

2022 · 35 filings — 29 × 4, 3 × SC 13G/A, 1 × 3 and 2 other forms

Counted, not listed; the year is on EDGAR.

2021 · 52 filings — 45 × 4, 3 × SC 13G/A, 2 × UPLOAD and 2 other forms

Counted, not listed; the year is on EDGAR.

2020 · 50 filings — 42 × 4, 3 × SC 13G/A, 2 × 4/A and 3 other forms

Counted, not listed; the year is on EDGAR.

2019 · 43 filings — 37 × 4, 4 × SC 13G/A, 1 × 3 and 1 other form

Counted, not listed; the year is on EDGAR.

2018 · 34 filings — 20 × 4, 5 × SC 13G/A, 3 × UPLOAD and 5 other forms

Counted, not listed; the year is on EDGAR.

2017 · 50 filings — 36 × 4, 3 × SC 13G/A, 3 × UPLOAD and 6 other forms

Counted, not listed; the year is on EDGAR.

2016 · 43 filings — 38 × 4, 4 × SC 13G/A, 1 × 3

Counted, not listed; the year is on EDGAR.

2015 · 36 filings — 24 × 4, 7 × 4/A, 4 × SC 13G/A and 1 other form

Counted, not listed; the year is on EDGAR.

2014 · 45 filings — 32 × 4, 7 × SC 13G/A, 5 × 3 and 1 other form

Counted, not listed; the year is on EDGAR.

2013 · 32 filings — 18 × 4, 8 × SC 13G/A, 3 × 3 and 2 other forms

Counted, not listed; the year is on EDGAR.

2012 · 21 filings — 15 × 4, 4 × SC 13G/A, 1 × 3 and 1 other form

Counted, not listed; the year is on EDGAR.

2011 · 23 filings — 19 × 4, 3 × SC 13G/A, 1 × 4/A

Counted, not listed; the year is on EDGAR.

2010 · 28 filings — 19 × 4, 3 × SC 13G/A, 2 × UPLOAD and 4 other forms

Counted, not listed; the year is on EDGAR.

2009 · 22 filings — 14 × 4, 2 × SC 13G, 2 × SC 13G/A and 4 other forms

Counted, not listed; the year is on EDGAR.

2008 · 22 filings — 15 × 4, 2 × SC 13G/A, 2 × UPLOAD and 3 other forms

Counted, not listed; the year is on EDGAR.

2007 · 24 filings — 18 × 4, 2 × 4/A, 2 × SC 13G/A and 2 other forms

Counted, not listed; the year is on EDGAR.

2006 · 33 filings — 23 × 4, 3 × CORRESP, 2 × SC 13G and 3 other forms

Counted, not listed; the year is on EDGAR.

2005 · 27 filings — 21 × 4, 3 × SC 13G/A, 1 × 3 and 2 other forms

Counted, not listed; the year is on EDGAR.

2004 · 28 filings — 17 × 4, 4 × SC 13G/A, 2 × CORRESP and 5 other forms

Counted, not listed; the year is on EDGAR.

2003 · 26 filings — 20 × 4, 3 × SC 13G/A, 1 × 3 and 2 other forms

Counted, not listed; the year is on EDGAR.

2002 · 5 filings — 4 × SC 13G/A, 1 × SC 13G

Counted, not listed; the year is on EDGAR.

2001 · 4 filings — 4 × SC 13G/A

Counted, not listed; the year is on EDGAR.

2000 · 7 filings — 4 × SC 13G/A, 2 × SC 13G, 1 × S-8

Counted, not listed; the year is on EDGAR.

1999 · 4 filings — 3 × SC 13G/A, 1 × S-8

Counted, not listed; the year is on EDGAR.

1998 · 8 filings — 6 × SC 13G/A, 1 × S-3, 1 × SC 13D/A

Counted, not listed; the year is on EDGAR.

1997 · 5 filings — 4 × SC 13G/A, 1 × S-8

Counted, not listed; the year is on EDGAR.

1996 · 4 filings — 3 × SC 13G/A, 1 × S-8

Counted, not listed; the year is on EDGAR.

1995 · 1 filing — 1 × POS AM

Counted, not listed; the year is on EDGAR.

About this data#

Bio-Techne (TECH) has 1,279 filings on EDGAR going back to 1995: 35 annual reports, 97 quarterly reports and 187 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Aug 24, 2026 for the fiscal year ended Jun 30, 2026. The most recent 8-K, on Nov 4, 2026, covered other events. Over the last 13 months insiders sold $437K in 2 sales and bought nothing on the open market; 101 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.

Every row is a filing EDGAR lists for the registrants that have been Bio-Techne, read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.

Head-to-head:Compare with DXCM or any ticker →

FAQ#

Where can I read TECH's latest 10-K?: TECH's latest annual report, a 10-K, was filed on Aug 24, 2026 for the fiscal year ended Jun 30, 2026. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
When did TECH last file an 8-K?: On Nov 4, 2026 it covered other events. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 12, 2026.
Are TECH insiders buying or selling?: Over the last 13 months insiders sold $437K in 2 sales and bought nothing on the open market; 101 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Herr Amy E. (Director) sold 6,636 shares on May 8, 2026 for $320K. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
How many SEC filings has TECH made?: 1,279 filings are on EDGAR under the registrant records that have been Bio-Techne, going back to 1995; 708 of them are insider ownership forms (Forms 3, 4, 5 and 144).

TECH SEC filings (2026)

What happened, last 12 months#

November 2026

October 2026

September 2026

August 2026

July 2026

June 2026

May 2026

February 2026

Insider transactions#

Reports and proxy statements#

Insider, ownership and other filings#

About this data#

FAQ#